EXORPHIA is a company headquartered in Japan.
EXORPHIA is a biotechnology startup developing extracellular vesicle (EV) technologies to improve embryo quality and success rates in in vitro fertilization (IVF) and pioneering exosome-based drug discovery for treating intractable diseases.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.